ARP Research and Funding Priorities

Funding Priorities:

• Fiscal Year 2013 Funding Priorities (PDF 250KB)
• Fiscal Year 2012 Funding Priorities (PDF 127KB)

Research Priorities:

Domestic:

• Reducing racial/ethnic disparities in HIV testing, access, and utilization of treatment and services
• Seek, test, treat, and retain—expanding HIV testing, linkage, and retention in care for hard-to-reach populations
• Improving effectiveness of HIV therapy for substance abusers
• Drug treatment as HIV prevention
• Understanding transmission of HIV among drug users (both injection and non-injection) and their networks
• Interventions for drug users involved in the criminal justice system
• Research on  substance abuse, risky decision-making, and impulsivity and HIV transmission among adolescents and adults
• Strategies to coordinate and improve treatment and services for HIV, drug abuse, and co-occurring conditions (e.g., HCV)
• Enhancing adherence to treatment for HIV and comorbid conditions
• Drug abuse, HIV, and the brain
• Genetics, epigenetics, proteomics, and systems biology studies in drug abusers and/or animal models of HIV
• Research on structural interventions to prevent HIV/AIDS transmission and/or to enhance access/utilization of treatment and services
• Training of new AIDS researchers

International:

• Develop prevention strategies addressing non-injection drug use such as stimulants (e.g. methamphetamine, cocaine, crack) in vulnerable populations (e.g., MSM, young women) where prevalence is high (e.g., Latin America, Asia, Africa)
• Develop prevention strategies addressing HIV/injection drug use epidemics in different geographic areas (Russia, China, SE Asia, India, Eastern/Central Europe)
• Develop regional research networks
• Develop new methods for gathering HIV epidemiological data and tracking HIV diffusion
• Assess role of immigration and migration on HIV transmission
• Drug treatment as HIV prevention, including development of long-acting, sustainable therapies
• Assessment of HIV/AIDS treatment as HIV prevention
• Implementation science research to guide scale-up of cost-effective interventions
• HIV and co-infections (e.g., HCV, TB)
• Support training new AIDS researchers